Author

Daryoush Shahbazi-Gahrouei

Professor of Medical Physics, Isfahan University of Medical Sciences - Cited by 2,503 - Advanced radiation Therapy - Molecular imaging - MR imaging and Nanomedicine - Radiation dosimetry - Nuclear Medicine

Biography

Daryoush Shahbazi-Gahrouei obtained his BSc from the Department of Science of Isfahan University in Iran in 1987, and his MSc from the School of Medical Sciences of Tarbiat Modarres University, Tehran, Iran, in 1991. He obtained his PhD in Medical Physics at the University of Western Sydney and St. George Cancer Care Centre, Sydney, Australia, in 2000.
Title
Cited by
Year
Trastuzumab conjugated porphyrin-superparamagnetic iron oxide nanoparticle: A potential PTT-MRI bimodal agent for herceptin positive breast cancer
PM Khaniabadi, D Shahbazi-Gahrouei, AA Aziz, MA Dheyab, ...Photodiagnosis and photodynamic therapy 31 (2020), 101896, 2020202
34
2020
Essential considerations for accurate evaluation of photoneutron contamination in Radiotherapy
AH Karimi, H Brkić, D Shahbazi-Gahrouei, SB Haghighi, I JabbariApplied Radiation and Isotopes 145, 24-31, 2019201
27
2019
Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection
Z Salehnia, D Shahbazi-Gahrouei, A Akbarzadeh, B Baradaran, ...IET Nanobiotechnology 13 (4), 400-406, 202
19
2019
Pineapple extract as an efficient anticancer agent in treating human cancer cells
E Raeisi, D Shahbazi-Gahrouei, E HeidarianImmunopharmacogenetics 1, 2019201
17
2019
A literature review on multimodality molecular imaging nanoprobes for cancer detection
D Shahbazi-Gahrouei, PM Khaniabadi, S Shahbazi-Gahrouei, ...Polish Journal of Medical Physics and Engineering 25 (2), 57-68, 2019201
17
2019
Synthesis and application of Fe3O4@ Au composite nanoparticles as magnetic resonance/computed tomography dual-modality contrast agent
M Keshtkar, D Shahbazi-Gahrouei, A MahmoudabadiJournal of Medical Signals and Sensors 10 (3), 201-207, 2020202
13
2020
Optimal scheduling of the nanoparticle-mediated cancer photo-thermo-radiotherapy
A Safari, A Sarikhani, D Shahbazi-Gahrouei, Z Alamzadeh, J Beik, ...Photodiagnosis and Photodynamic Therapy 32 (2020), 102061, 2020202
12
2020
In vivo study of anti‐epidermal growth factor receptor antibody‐based iron oxide nanoparticles (anti‐EGFR‐SPIONs) as a novel MR imaging contrast agent for lung cancer (LLC1 …
D Shahbazi‐Gahrouei, N Abdi, S Shahbazi‐Gahrouei, SH Hejazi, ...IET nanobiotechnology 14 (5), 36-374, 2020202
9
2020
Recent nanotheranostics applications for cancer therapy and diagnosis: A review
F Aminolroayaei, D Shahbazi‐Gahrouei, S Shahbazi‐Gahrouei, ...IET Nanobiotechnology 15 (3), 247-256, 2021202
8
2021
Study the Anti-MUC1 antibody-based iron oxide nanoparticles on three-dimension spheroid and breast cancer (MCF-7) cell imaging
Study the Anti-MUC1 antibody-based iron oxide nanoparticles on three-dimension spheroid and breast cancer (MCF-) cell imagingPM Khaniabadi, D Shahbazi-Gahrouei, AMSA Majid, BM KhaniabadiPolish Journal of Medical Physics and Engineering 25 (2), 69-, 2019201
7
2019
A review on theranostic applications of iodine nanoparticles: Recent findings and perspectives
M Manouri, D Shahbazi-GahroueiNanomedicine Journal 8 (4), 234-240, 2021202
6
2021
The role of the spatially fractionated radiation therapy in the management of advanced bulky tumors
F Mahmoudi, D Shahbazi-Gahrouei, N ChegeniPolish Journal of Medical Physics and Engineering 27 (2), 123-135, 2021202
6
2021
Rapid delivery of gold nanoparticles into colon cancer HT-29 cells by electroporation: In-vitro study
Z Arab-Bafrani, D Shahbazi-Gahrouei, M AbbasianJournal of Biomedical Physics & Engineering 10 (2), 161-166, 2020202
5
2020
Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent
T Almasi, N Gholipour, M Akhlaghi, A Mokhtari Kheirabadi, SM Mazidi, ...International Journal of Polymeric Materials and Polymeric Biomaterials 70 …, 2021202
5
2021
The Radioprotective Effect of Ascorbic Acid and Kefir against Genotoxicity Induced by Exposure in Mice Blood Lymphocytes
F Koohian, D Shahbazi-Gahrouei, M Koohiyan, A ShaneiNutrition and Cancer 73 (3), 34-40, 2021202
5
2021
Radiation Exposure and Lifetime Attributable Risk of Cancer Incidence and Mortality from Low- and Standard-Dose CT Chest: Implications for COVID-19 Pneumonia Subjects
M Garg, V Karami, J Moazen, T Kwee, AS Bhalla, D Shahbazi-Gahrouei, ...Diagnostics 12 (12), 3043, 2022202
5
2022
Estimation of absorbed dose of the thyroid gland in patients undergoing 64-slice head computed tomography and comparison the results with ImPACT software and computed …
Estimation of absorbed dose of the thyroid gland in patients undergoing 6-slice head computed tomography and comparison the results with ImPACT software and computed …A Maziar, R Paydar, G Azadbakht, D Shahbazi-GahroueiJ Med Signals Sens 9 (3), 190-195, 2019201
4
2019
A Novel GPU-based Fast Monte Carlo Photon Dose Calculating Method for Accurate Radiotherapy Treatment Planning
M Karbalaee, D Shahbazi-Gahrouei, MB TavakoliJournal of Biomedical Physics & Engineering 10 (3), 329-30, 2020202
4
2020
Dosimetric characteristics of Lithium triborate (LiB3O5) nanophosphor for medical applications
A Abdi Saray, P Kaviani, D Shahbazi-GahroueiRadiation Measurements 140 (2021), 106502, 20204202
4
2020
Assessment of ploy dopamine coated Fe3O4 nanoparticles for melanoma (B16-F10 and A-375) cells detection
Assessment of ploy dopamine coated Fe3O nanoparticles for melanoma (B16-F10 and A-375) cells detectionFH Beigi, S Fatahian, S Shahbazi-Gahrouei, D Shahbazi-Gahrouei, ...Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020202
4
2020

Referred From: https://scholar.google.com/citations?user=pPhFPlUAAAAJ&hl=en

Cited by
Citations 2503
h-index 27
i10-index 82
Open Access Journals